Sunscreen Innovation Act Illuminates ‘Good Things’ For OTC Monograph Reform
This article was originally published in The Tan Sheet
Executive Summary
The Sunscreen Innovation Act’s more efficient process provides a model for OTC monograph reform, says nonprescription drugs office chief Theresa Michele. At a CHPA conference, she says a key change under the act is eliminating some administrative steps required for other monograph proposals.